SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-030227
Filing Date
2014-05-14
Accepted
2014-05-14 11:17:30
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v377121_10q.htm 10-Q 338152
2 EXHIBIT 10.1 v377121_ex10-1.htm EX-10.1 121681
3 EXHIBIT 31.1 v377121_ex31-1.htm EX-31.1 11429
4 EXHIBIT 32.1 v377121_ex32-1.htm EX-32.1 5242
  Complete submission text file 0001144204-14-030227.txt   4205681

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT antb-20140331.xml EX-101.INS 522519
6 XBRL TAXONOMY EXTENSION SCHEMA antb-20140331.xsd EX-101.SCH 59281
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE antb-20140331_cal.xml EX-101.CAL 35119
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE antb-20140331_def.xml EX-101.DEF 243679
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE antb-20140331_lab.xml EX-101.LAB 360403
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE antb-20140331_pre.xml EX-101.PRE 285262
Mailing Address 890 SANTA CRUZ AVENUE MENLO PARK CA 94025
Business Address 890 SANTA CRUZ AVENUE MENLO PARK CA 94025 650-847-1919
AntriaBio, Inc. (Filer) CIK: 0001509261 (see all company filings)

IRS No.: 273440894 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54495 | Film No.: 14839955
SIC: 2834 Pharmaceutical Preparations